1. Yoshizaki, T., Ito, M., Murono, S., Wakisaka, N., Kondo, S., & Endo, K. (2012). Current understanding and management of nasopharyngeal carcinoma. Auris Nasus Larynx, 39, 137–144.
2. Yoshizaki, T., Kondo, S., Wakisaka, N., Murono, S., Endo, K., Sugimoto, H., et al. (2013). Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma. Cancer Letters, 337, 1–7.
3. Yoshizaki, T., Wakisaka, N., & Pagano, J. S. (2005). Epstein-Barr virus, invasion and metastasis. In E. S. Robertson (Ed.), Epstein-Barr virus (pp. 171–196). Norfolk: Caister Academic.
4. Parkin, D. M., Muir, C. S., Whelan, S. L., & Gao, Y. T. (2002). Cancer incidence in five continents. IARC Scientific Publications, VIII, 1–781.
5. Nielsen, N. H., Mikkelsen, F., & Hansen, J. P. (1977). Nasopharyngeal cancer in Greenland, the incidence in an Arctic Eskimo population. Acta Pathologica et Microbiologica Scandinavica Section A, 85, 850–858.